189 related articles for article (PubMed ID: 26968550)
1. Expression of activated molecules on CD5(+)B lymphocytes in autoimmune hemolytic anemia.
Zhu H; Xu W; Liu H; Wang H; Fu R; Wu Y; Qu W; Wang G; Guan J; Song J; Xing L; Shao Z
Int J Hematol; 2016 May; 103(5):545-53. PubMed ID: 26968550
[TBL] [Abstract][Full Text] [Related]
2. Expression of BTK/p-BTK is different between CD5
Duan N; Zhao M; Wang Y; Qu Y; Liu H; Wang H; Xing L; Shao Z
Hematology; 2019 Dec; 24(1):588-595. PubMed ID: 31392938
[No Abstract] [Full Text] [Related]
3. B cells CD19+ in patients with B-cell chronic lymphocytic leukaemia and autoimmune haemolytic anaemia.
Słomkowski M; Kopeć-Szlezak J; Fabijańska-Mitek J; Podstawka U; Sikorska A; Mendek-Czajkowska E
Clin Lab Haematol; 2004 Dec; 26(6):385-9. PubMed ID: 15595995
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
5. CD5
Zhao M; Duan N; Wang Y; Zhu H; Liu H; Wang H; Xing L; Shao Z
Autoimmunity; 2019 Feb; 52(1):12-20. PubMed ID: 30784322
[TBL] [Abstract][Full Text] [Related]
6. The pathologic significance of the immunoglobulins expressed by chronic lymphocytic leukemia B-cells in the development of autoimmune hemolytic anemia.
Efremov DG; Ivanovski M; Burrone OR
Leuk Lymphoma; 1998 Jan; 28(3-4):285-93. PubMed ID: 9517500
[TBL] [Abstract][Full Text] [Related]
7. [The clinical significance of CD(4)(+)CD(69)(+) T lymphocytes in patients with autoimmune hemolytic anemia/Evans syndrome].
Xing LM; Xu WY; Duan NN; Qu YY; Liu ZY; Shao ZH
Zhonghua Nei Ke Za Zhi; 2018 Sep; 57(9):656-660. PubMed ID: 30180450
[No Abstract] [Full Text] [Related]
8. Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia.
Sthoeger ZM; Sthoeger D; Shtalrid M; Sigler E; Geltner D; Berrebi A
Am J Hematol; 1993 Aug; 43(4):259-64. PubMed ID: 7690517
[TBL] [Abstract][Full Text] [Related]
9. Subtypes of B lymphocytes in patients with autoimmune hemocytopenia.
Xing LM; Shao ZH; Fu R; Liu H; Shi J; Bai J; Tu MF; Wang HQ; Cui ZZ; Jia HR; Sun J; Yang CL
Chin Med Sci J; 2007 Jun; 22(2):128-31. PubMed ID: 17763587
[TBL] [Abstract][Full Text] [Related]
10. miR-150 regulates B lymphocyte in autoimmune hemolytic anemia/Evans syndrome by c-Myb.
Xing L; Xu W; Qu Y; Zhao M; Zhu H; Liu H; Wang H; Su X; Shao Z
Int J Hematol; 2018 Jun; 107(6):666-672. PubMed ID: 29488168
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.
Allgeier T; Garhammer S; Nössner E; Wahl U; Kronenberger K; Dreyling M; Hallek M; Mocikat R
Cancer Lett; 2007 Jan; 245(1-2):275-83. PubMed ID: 16516377
[TBL] [Abstract][Full Text] [Related]
12. [Expression of CD5 antigen in B and T cells from umbilical cord blood, from blood of healthy adults and patients with chronic lymphocytic B-cell leukemia (PBL-B)].
Roliński J; Rupniewska ZM; Wasik-Szczepanek E
Pol Arch Med Wewn; 1999 Apr; 101(4):307-14. PubMed ID: 10740408
[TBL] [Abstract][Full Text] [Related]
13. Direct or reverse correlations within the expression of activation, differentiation or T-B cooperation molecules on chronic lymphocytic leukemia B cells.
Sellitto A; De Fanis U; Romano C; Dalla Mora L; Guastafierro S; Tirelli A; Lucivero G
Minerva Med; 2003 Oct; 94(5):331-6, 336-9. PubMed ID: 14973427
[TBL] [Abstract][Full Text] [Related]
14. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 6 exacerbates the progression of warm autoimmune hemolytic anemia by influencing the activity and function of B cells.
Zhao M; Chen L; Yang J; Zhang Z; Wang H; Shao Z; Liu X; Xing L
Sci Rep; 2023 Aug; 13(1):13231. PubMed ID: 37580421
[TBL] [Abstract][Full Text] [Related]
16. Comparative flow cytometric evaluation of bcl-2 oncoprotein in CD5+ and CD5- B-cell lymphoid chronic leukemias.
Molica S; Mannella A; Crispino G; Dattilo A; Levato D
Haematologica; 1997; 82(5):555-9. PubMed ID: 9407720
[TBL] [Abstract][Full Text] [Related]
17. [Chronic cold agglutinin disease accompanied with an increase of CD20+/CD5+ cells; a case report].
Notoya A; Hirayama S; Takano H; Koizumi K; Satoh N; Yasukouchi T; Sawada K; Koike T
Rinsho Ketsueki; 1994 Sep; 35(9):881-5. PubMed ID: 7526015
[TBL] [Abstract][Full Text] [Related]
18. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
[TBL] [Abstract][Full Text] [Related]
19. Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy.
Spaner DE; Hammond C; Mena J; Shi Y
Br J Haematol; 2004 Dec; 127(5):531-42. PubMed ID: 15566356
[TBL] [Abstract][Full Text] [Related]
20. [Lymphocyte subpopulations determined by flow cytometry in chronic type B lymphatic leukemia].
Kvasnicka J; Kruzík P; Cmunt E; Neurwirtová R
Cas Lek Cesk; 1994 Aug; 133(16):506-10. PubMed ID: 7923329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
